Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck

Table 1 Patient and treatment characteristics

Table 1	n	%		n	%
Gender			Age
Male	18	69	Median	64 years
Female	8	31	Range	19–88 years
Situation			Size
Primary	22	85	Median	4.6 cm
Recurrent	4	15	Range	1–12 cm
Location			Grading
Skull*	8	31	1	1	4
Sinus/orbit	7	27	2	8	31
Neck‘	11	42	3	17	65
Histology			T stage
Angiosarcoma	9	35	1a	4	15
MFH/undiff. pleo.	5	19	1b	10	38
Synovial	4	15	2b	12	46
Other	8	31
N stage			CHT
N0	24	92	Yes	13	50
N1	2	8	None	13	50
Clinical stage			Surgery
Ia	1	4	R0	10	38
IIa	13	50	R1	6	23
IIb	4	15	R2	5	19
III	8	31	None	5	19
RT dose (PT)			ENI
Median	66 Gy		Yes	14	54
Range	45–72 Gy		No	12	46
RT technique
3D-CRT	17	65
IMRT	7	27
Electrons	2	8

*: includes skin, ‘: includes larynx/pharynx, MFH: malignant fibrous histiocytoma, undiff. pleo.: undifferentiated pleomorphic sarcoma, RT: radiation therapy, PT: primary tumor region, 3D-CRT: 3d-conformal radiation therapy, IMRT: intensity-modulated radiation therapy, cm: centimeter, CHT: chemotherapy, ENI: elective nodal irradiation (ipsilateral cervical nodes)

ISSN: 1748-717X